ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette–Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC).
Saved in:
| Title: | ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette–Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC). |
|---|---|
| Authors: | Roupret, M.1 (AUTHOR) morgan.roupret@aphp.fr, Bertaut, A.2 (AUTHOR), Pignot, G.3 (AUTHOR), Neuzillet, Y.4 (AUTHOR), Houede, N.5 (AUTHOR), Mathieu, R.6 (AUTHOR), Corbel, L.7 (AUTHOR), Besson, D.8 (AUTHOR), Seisen, T.1 (AUTHOR), Jaffrelot, L.9 (AUTHOR), Lebacle, C.10 (AUTHOR), Champiat, S.11 (AUTHOR), Lebdai, S.12 (AUTHOR), Timsit, M.-O.13 (AUTHOR), Thibault, C.14 (AUTHOR), Goeman, L.15 (AUTHOR), Juárez Soto, Á.16 (AUTHOR), La, C.17 (AUTHOR), Léger, C.17 (AUTHOR), Loriot, Y.1,18 (AUTHOR) yohann.loriot@gustaveroussy.fr |
| Source: | Annals of Oncology. Jan2026, Vol. 37 Issue 1, p44-52. 9p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 190357529 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette–Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Roupret%2C+M%2E%22">Roupret, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> morgan.roupret@aphp.fr</i><br /><searchLink fieldCode="AR" term="%22Bertaut%2C+A%2E%22">Bertaut, A.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pignot%2C+G%2E%22">Pignot, G.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Neuzillet%2C+Y%2E%22">Neuzillet, Y.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Houede%2C+N%2E%22">Houede, N.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mathieu%2C+R%2E%22">Mathieu, R.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Corbel%2C+L%2E%22">Corbel, L.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Besson%2C+D%2E%22">Besson, D.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Seisen%2C+T%2E%22">Seisen, T.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jaffrelot%2C+L%2E%22">Jaffrelot, L.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lebacle%2C+C%2E%22">Lebacle, C.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Champiat%2C+S%2E%22">Champiat, S.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lebdai%2C+S%2E%22">Lebdai, S.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Timsit%2C+M%2E-O%2E%22">Timsit, M.-O.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Thibault%2C+C%2E%22">Thibault, C.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Goeman%2C+L%2E%22">Goeman, L.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Juárez+Soto%2C+Á%2E%22">Juárez Soto, Á.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22La%2C+C%2E%22">La, C.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Léger%2C+C%2E%22">Léger, C.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Loriot%2C+Y%2E%22">Loriot, Y.</searchLink><relatesTo>1,18</relatesTo> (AUTHOR)<i> yohann.loriot@gustaveroussy.fr</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Jan2026, Vol. 37 Issue 1, p44-52. 9p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=190357529 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.09.017 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 9 StartPage: 44 Titles: – TitleFull: ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette–Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Roupret, M. – PersonEntity: Name: NameFull: Bertaut, A. – PersonEntity: Name: NameFull: Pignot, G. – PersonEntity: Name: NameFull: Neuzillet, Y. – PersonEntity: Name: NameFull: Houede, N. – PersonEntity: Name: NameFull: Mathieu, R. – PersonEntity: Name: NameFull: Corbel, L. – PersonEntity: Name: NameFull: Besson, D. – PersonEntity: Name: NameFull: Seisen, T. – PersonEntity: Name: NameFull: Jaffrelot, L. – PersonEntity: Name: NameFull: Lebacle, C. – PersonEntity: Name: NameFull: Champiat, S. – PersonEntity: Name: NameFull: Lebdai, S. – PersonEntity: Name: NameFull: Timsit, M.-O. – PersonEntity: Name: NameFull: Thibault, C. – PersonEntity: Name: NameFull: Goeman, L. – PersonEntity: Name: NameFull: Juárez Soto, Á. – PersonEntity: Name: NameFull: La, C. – PersonEntity: Name: NameFull: Léger, C. – PersonEntity: Name: NameFull: Loriot, Y. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: Jan2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 37 – Type: issue Value: 1 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |